@Article{Rejdak2011,
journal="Klinika Oczna / Acta Ophthalmologica Polonica",
issn="0023-2157",
volume="113",
number="4",
year="2011",
title="Emerging therapies for the treatment of wet age-related macular degeneration – VEGF Trap-Eye",
abstract="Age-related macular degeneration (AMD) is the leading cause of blindness in the industrialized world. The most severe form of this disease is exudative AMD. It accounts for 10% of cases of AMD and is responsible for approximately 90% cases of severe vision loss due to AMD. Anti-vascular endothelial growth factor (VEGF) therapy changed the standard-of-care for this blinding disease. This article presents one promising new drug for the treatment of exudative AMD – VEGF Trap-Eye.",
author="Rejdak, Robert
and Szkaradek, Małgorzata
and Grieb, Paweł
and Jünemann, Anselm G.M.",
pages="376--378",
url="https://www.termedia.pl/Emerging-therapies-for-the-treatment-of-wet-age-related-macular-degeneration-VEGF-Trap-Eye,124,48430,1,1.html"
}